Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd Updates
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Hon'ble Supreme Court vide its interim order dated August 11, 2017, in the matter relating to M/s Daiichi Sankyo Company Limited v/s Oscar Investments Limited & Others, directed that status quo as on date with regard to shareholding of M/s Fortis Healthcare Holding Private Limited, one of the Promoter Group Entity in the Company be maintained.... Broker's call
IDFC SecuritiesFortis Healthcare (Outperformer)CMP: 159.85Target: 197Post a prolonged process of cleaning up its balance sheet through divestment of the international assets, Fortis Healthcare Ltd... Updates
Please find enclosed the Investors' Presentation on financial Statements for the Quarter ended on June 30, 2017 pursuant to Regulation 30, Schedule III, Part A (15) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to take the same on your record. Updates
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 and SEBI (Share Based Employee Benefits) Regulations), 2014, we would like to inform you that in terms of 'Employee Stock Option Scheme 2011', the Nomination & Remuneration Committee of the Company had at its meeting held on August 4, 2017, approved grant of 25,00,000 (Twenty Five Lac) Stock Options at an Exercise Price of Rs. 163.30/-... Fortis net falls 10% in Q1
Fortis Healthcare has registered a slowdown in profit during the first quarter of this fiscal. The company's consolidated net profit dipped 10 per cent during the quarter ended June 30, 2017, at... Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd Outcome of Board Meeting (AGM on Sept 26, 2017)
Fortis Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 04, 2017, inter alia, has considered and approved the following:- Convening of 21st Annual General Meeting of the Company on September 26, 2017, at 12.00 noon at National Institute of Pharmaceutical Education and Research Mohali, Sector 67, SAS Nagar, Mohali-Punjab - 1600 062. Outcome of Board Meeting
This is to inform you that the Board of Directors of the Company at its meeting held today, inter-alia, considered and approved the following: 1.Un-Audited Financial Results and Limited Review Report of the Company for the quarter ended on June 30, 2017; 2.Recommendation for appointment of Mr. Harpal Singh, Director of the Company, liable to retire by rotation at the ensuing Annual General Meeting, subject to the approval of the shareholders;...